CAPR Past Earnings image   This CAPR past earnings page last updated 5/15/2024
CAPR Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/13/2024-0.310
Q4 20232/29/2024-0.020
Q3 202311/14/2023-0.250
Q2 20238/7/2023-0.290
Q1 20235/11/2023-0.310
Q4 20223/15/2023-0.310
Q3 202211/10/2022-0.260
Q2 20228/10/2022-0.290
Q1 20225/10/2022-0.320
Q4 20213/10/2022-0.260
Q3 202111/9/2021-0.170
Q2 20218/12/2021-0.220
Q1 20215/13/2021-0.230
Q4 20203/11/2021-0.210
Q3 202011/12/2020-0.200
Q2 20208/6/2020-0.230
Q1 20205/14/2020-0.300
Q4 20193/18/2020-0.340
Q3 201911/7/2019-0.430
Q2 20198/6/2019-0.590
Q1 20195/13/2019-0.800
Q4 20183/28/2019-1.100
Q3 201811/13/2018-1.400
Q2 20188/9/2018-1.400
Q1 20185/10/2018-1.400
Q4 20173/14/2018-1.100
Q3 201711/8/2017-1.200
Q2 20178/10/2017-1.600
Q1 20175/15/2017-1.700
Q4 20163/15/2017-2.100
Q3 201611/10/2016-2.900
Q2 20168/15/2016-2.600
Q1 20165/12/2016-2.600
CAPR Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/13/20240.00B
Q4 20232/29/20240.01B
Q3 202311/14/20230.01B
Q2 20238/7/20230.00B
Q1 20235/11/20230.00B
Q4 20223/15/20230.00B
Q3 202211/10/20220.00B
Q2 20228/10/2022NA
Q1 20225/10/2022NA
Q4 20213/10/2022NA
Q3 202111/9/2021NA
Q2 20218/12/20210.00B
Q1 20215/13/20210.04M
Q4 20203/11/20210.06M
Q3 202011/12/20200.02M
Q2 20208/6/20200.05M
Q1 20205/14/20200.00B
Q4 20193/18/20200.00B
Q3 201911/7/20190.00B
Q2 20198/6/20190.00B
Q1 20195/13/20190.00B
Q4 20183/28/2019648082
Q3 201811/13/2018219247
Q2 20188/9/2018403960
Q1 20185/10/2018400066
Q4 20173/14/2018475799
Q3 201711/8/2017313271
Q2 20178/10/2017996462
Q1 20175/15/2017880808
Q4 20163/15/2017906930
Q3 201611/10/2016746781
Q2 20168/15/20161.13M
Q1 20165/12/20161.22M
Quotes delayed 20 minutes

Email EnvelopeFree CAPR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Capricor Therapeutics (CAPR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CARA Past Earnings
CARM Past Earnings
CASI Past Earnings
CATB Past Earnings
CBAY Past Earnings
CBIO Past Earnings
CBUS Past Earnings
CCCC Past Earnings
CCEL Past Earnings
CCRN Past Earnings

CAPR Past Earnings Q&A

What was the best and worst CAPR past earnings results?
For Capricor Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CAPR past earnings result in our data set was -0.020/share posted in Q4 2023, while the lowest was in Q3 2016 when CAPR posted -2.900/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2023 when CAPR reported 0.01B in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.

  Suggested answer: There are 33 CAPR past earnings results in our data set.

On this page we presented the CAPR past earnings date information for Capricor Therapeutics. Reviewing that CAPR Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2023, when CAPR posted gaap of -0.020/share. Meanwhile the lowest CAPR past earnings result was in Q3 2016, when CAPR posted gaap of -2.900/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2023 when CAPR reported 0.01B in revenue, while the smallest revenue quarter was Q2 2022 when CAPR reported NA in revenue.

Any self directed investor doing their due diligence on CAPR or any other given stock can benefit from researching all of the Capricor Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Capricor Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CAPR. Thanks for visiting, and the next time you need to research CAPR past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding JJCB, Institutional Holders of GCV, Top Ten Hedge Funds Holding MR.


CAPR Past Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.